Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2013
08/15/2013WO2012094651A8 Scn5a splice variants for use in methods relating to sudden cardiac death and need for implanted cadiac defibrillators
08/15/2013US20130212740 Fucosyl transferase gene
08/15/2013US20130212734 Genetic loci associated with resistance of corn to fijivirus
08/15/2013US20130212716 PFKs as Modifiers of the IGFR Pathway and Methods of Use
08/15/2013US20130211100 Method to Generate Novel Bioactive Molecules
08/15/2013US20130210900 ARID1A and PPP2R1A Mutations in Cancer
08/15/2013US20130210892 Method of Treatment
08/15/2013US20130210888 Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
08/15/2013US20130210843 Predictive marker for egfr inhibitor treatment
08/15/2013US20130210802 Imidazopyridines syk inhibitors
08/15/2013US20130210752 Using a novel high-throughput yeast cell-based screening platform to identify hmg-coa reductase inhibitors from natural products and the uses of such inhibitors thereof
08/15/2013US20130210699 Methods and Compositions for Diagnosing and Treating Cervical Intraepithelial Neoplasia and Cervical Cancer
08/15/2013US20130210682 Microdevices and biosensor cartridges for biological or chemical analysis and systems and methods for the same
08/15/2013US20130210675 Compositions and methods for controlled release of biomolecules
08/15/2013US20130210674 Whole genome expression analysis system
08/15/2013US20130210673 Polypeptide Display Libraries and Methods of Making and Using Thereof
08/15/2013US20130210670 Method for determining a biological pathway activity
08/15/2013US20130210668 Method for determination of progression risk of glaucoma
08/15/2013US20130210666 Markers of the Male Urogenital Tract
08/15/2013US20130210660 Method for Active Hybridization in Microarrays with Denaturing Function
08/15/2013US20130210659 Molecular diagnostic screening assay
08/15/2013US20130210658 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
08/15/2013US20130210657 Method of Determining Risk of Autism Spectrum Disorder
08/15/2013US20130210656 Late-pcr
08/15/2013US20130210655 Microarray with enhanced specificity
08/15/2013US20130210653 Scanning multifunctional particles
08/15/2013US20130210652 Nanotechnology enabled point of care testing device
08/15/2013US20130210650 Peripheral gene expression biomarkers for autism
08/15/2013US20130210646 Hemomosaic: high-throughput technique for rare cell detection in liquid samples by massively multiplexed pcr in a photolithographic matrix
08/15/2013US20130210645 Personalized tumor biomarkers
08/15/2013US20130210644 Fetal aneuploidy detection by sequencing
08/15/2013US20130210643 Method for preparing a counter-tagged population of nucleic acid molecules.
08/15/2013US20130210642 Hybridization-Mediated Analysis Of Polymorphisms
08/15/2013US20130210641 Methods and apparatus for measuring analytes using large scale fet arrays
08/15/2013US20130210640 Assay systems for genetic analysis
08/15/2013US20130210639 Microfluidic devices
08/15/2013US20130210638 Methods for sequencing nucleic acid
08/15/2013US20130210637 Sol-gel chip using porous substrate for entrapping small molecules and screening method of small molecules specific material using thereof
08/15/2013US20130210636 Method and Kit for Performing Profiling of Endarterectomy Patients
08/15/2013US20130210149 Human g-protein chemokine receptor hsatu68
08/15/2013US20130210137 Methods of Modifying Eukaryotic Cells
08/15/2013US20130210127 System and method for processing and detecting nucleic acids
08/15/2013US20130210126 Microfluidic cartridge for processing and detecting nucleic acids
08/15/2013US20130210116 Composition and methods for the diagnosis and treatment of tumor
08/15/2013US20130210069 Biological sterilization indicator system and method
08/15/2013US20130210068 Substrate used for cell migration assays and method for cell migration assays
08/15/2013US20130210063 Compositions and assays for determining cell viability
08/15/2013US20130210062 In Vitro Cellular Bioassay for Neurotoxicity Testing
08/15/2013US20130210061 Method of Screening Damp-Dry Malodor Inhibitor and Method of Evaluating Damp-Dry Malodor Inhibitor
08/15/2013US20130210059 Method for Selecting Mevalonate Synthesis Modulators Using Cells Derived From Human Pluripotent Cells
08/15/2013US20130210057 Use of label-free biosensors to understand and identify treatment for cancer
08/15/2013US20130210056 Apparatus for producing high purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
08/15/2013US20130210054 Amino Acid Copolymer Assay
08/15/2013US20130210052 A Soluble and Stable Human 5-Lipoxygenase
08/15/2013US20130210050 Protease for proteomics
08/15/2013US20130210048 Method of detecting a biological activity
08/15/2013US20130210046 Screening methods for compounds that modulate the activity of g-protein coupled receptors
08/15/2013US20130210045 Biomarker for fatigue, and use thereof
08/15/2013US20130210044 Method of lipid assay and reagent for use therein
08/15/2013US20130210023 Nucleic acid aptamers against plasmodium lactate dehydrogenase and histidine-rich protein ii and uses thereof for malaria diagnosis
08/15/2013US20130210022 Method of identifying an agent for inhibiting odor of pyrazine derivatives
08/15/2013US20130210021 Isolated Staphylococcus Pseudolugdunensis
08/15/2013US20130210020 Systems and methods for monitoring the amplification and dissociation behavior of dna molecules
08/15/2013US20130210019 Helicase dependent isothermal amplification using nicking enzymes
08/15/2013US20130210017 Markers for determining chondrocytes
08/15/2013US20130210016 Nucleic acid detection and related compositions methods and systems
08/15/2013US20130210015 System and method for processing and detecting nucleic acids
08/15/2013US20130210014 Method for determining the prognosis and therapeutic response in chronic lymphocytic leukemia (cll) patients
08/15/2013US20130210013 Real time gene expression profiling
08/15/2013US20130210012 Method for assessing breast cancer susceptibility
08/15/2013US20130210011 Methods and biomarkers for detection of bladder cancer
08/15/2013US20130210010 Rapid salmonella serotyping assay
08/15/2013US20130210009 Conjugate between a thiophilic solid phase and an oligonucleotide comprising a thiooxonucleotide
08/15/2013US20130210008 Method for amplifying nucleic acids
08/15/2013US20130210007 Treatment and diagnosis of epigenetic disorders and conditions
08/15/2013US20130210006 Pericarp dna extraction and matrilineage determination
08/15/2013US20130210005 Method for detecting mycobacterium tuberculosis and nontuberculous mycobacteria by using dual real-time polymerase chain reaction
08/15/2013US20130210004 Egfr-related polypeptides and methods of use
08/15/2013US20130210003 Compositions for use in detection of multiple analytes
08/15/2013US20130210002 Method of analyzing cellular chromosomes
08/15/2013US20130210001 Sequence detection assay
08/15/2013US20130209999 Sqstm1 mutations in amyotrophic lateral sclerosis
08/15/2013US20130209998 Microbial Assay
08/15/2013US20130209997 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
08/15/2013US20130209996 Method for producing high purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
08/15/2013US20130209994 Fluorescent dyes
08/15/2013US20130209992 Methods of nonspecific target capture of nucleic acids
08/15/2013US20130209990 Detection of nucleic acids by type-specific hybrid capture methods
08/15/2013US20130209989 Oligonucleotide primer composition
08/15/2013US20130209987 Oligonucleotide sets for detection of human papillomavirus
08/15/2013US20130209635 Plants which synthesize a modified starch, process for the production thereof and modified starch
08/15/2013US20130209544 Microvesicles carrying small interfering rnas, preparation methods and uses thereof
08/15/2013US20130209486 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
08/15/2013US20130209473 R-spondin translocations and methods using the same
08/15/2013US20130209468 Use of MIF and MIF Pathway Agonists
08/15/2013US20130209460 Methods and kits used in identifying glioblastoma
08/15/2013US20130209452 Gene defects and mutant alk kinase in human solid tumors
08/15/2013US20130209451 Treatments for Cancer
08/15/2013US20130209447 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays
08/15/2013US20130209446 Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic Targets